Sign In
Buy CRSP
$52.08
+0.0600 (+0.115%)
At Close: Jun 03, 2026
Here's Why You Should Add CRISPR Stock to Your Portfolio
01:46pm, Tuesday, 21'st Mar 2023
CRISPR Therapeutics (CRSP), a top-ranked stock at present, is developing its lead pipeline candidate to treat TDT and SCD.
4 Biotech Stocks to Consider for Your Portfolio in 2023
01:00pm, Tuesday, 21'st Mar 2023
New drug approvals and pipeline progress should maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and a solid pipeline progress position CRSP, LGND, THRX and KAL
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
07:18pm, Saturday, 18'th Mar 2023
Healthcare costs in America and the world are set to rise in the foreseeable future. All thanks to an aging population, and the expectation that healthcare companies will be able to cure more of our d
CRISPR Therapeutics to Present at the American Association for Cancer Research 2023 Annual Meeting
06:02pm, Tuesday, 14'th Mar 2023
ZUG, Switzerland and BOSTON, March 14, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious dis
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
08:50am, Thursday, 09'th Mar 2023
CRISPR Therapeutics is a clinical-stage biotech company. The company's pipeline includes two promising wholly owned therapies.
2 Healthcare Stocks That Could Help Make You a Fortune
02:00pm, Wednesday, 08'th Mar 2023
CRISPR Therapeutics' first potential product may bring in blockbuster revenue. Intuitive Surgical is a leader by far -- in a market growing in the double-digits.
7 Cathie Wood Stocks for Your March Buy List
02:48pm, Tuesday, 07'th Mar 2023
Investing in Cathie Wood stocks means directing your money toward innovation. And that means investing heavily in tech, a sector that has been pummeled by interest rates held higher by a Federal Reser
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
12:13pm, Monday, 06'th Mar 2023
The 2022 Nobel Prize in Chemistry went to Emmanuelle Charpentier and Jennifer Doudna for their work on developing tools to change the genetic code of living cells, tools called CRISPR/Cas. Yet long be
Better Growth Stock: Moderna vs. CRISPR Therapeutics
05:30am, Sunday, 05'th Mar 2023
Moderna's pipeline programs may drive another huge phase of growth. The potential approval of CRISPR's first product could be a major catalyst for the stock.
3 Things About CRISPR Therapeutics That Smart Investors Know
07:25am, Saturday, 04'th Mar 2023
Institutional investors might be on to something.
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
09:15am, Friday, 03'rd Mar 2023
Investors are bidding up shares of these companies, and there are good reasons for doing so.
Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Gene Editing
09:24am, Thursday, 02'nd Mar 2023
The FDA cleared Intellia to begin testing its CRISPR gene-editing technology in people on Thursday, leading NTLA stock to jump. The post Intellia Therapeutics Stock Surges On A First-Ever In CRISPR Ge
Intellia's stock jumps as CRISPR therapy moves into Phase 2 clinical trial
08:09am, Thursday, 02'nd Mar 2023
Shares of Intellia Therapeutics Inc. NTLA, +1.44% rallied about 10% in premarket trading on Thursday after the company said the Food and Drug Administration will allow its experimental CRISPR therapy
Here's How Much You Can Make From Investing Your Tax Return Every Year
07:15am, Monday, 27'th Feb 2023
Doing this can strengthen your retirement plan.
CRISPR Therapeutics AG (CRSP) Presents at Citi's 2023 Virtual Oncology Leadership Summit Conference (Transcript)
08:11pm, Saturday, 25'th Feb 2023
CRISPR Therapeutics AG (NASDAQ:CRSP ) Citi's 2023 Virtual Oncology Leadership Summit Conference February 22, 2023 1:00 PM ET Company Participants Sam Kulkarni - CEO Conference Call Participants Yigal
